DMRA — Damora Therapeutics
Median target
$45.5
calls from the last 12 months
Implied return
+106.1%
median target vs. price
Coverage
9 analysts · 11 calls
updated in the last 12 months
Consensus
9/0/0+9 net
Buy / Hold / Sell
Which analysts are behind DMRA's consensus?
See every current rating, price target and the analysts' track records for Damora Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 9 analysts with calls on DMRA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
DMRA elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-25 | Insiders | Jarrett JenniferDirector,Officer | Insider purchase | 12.5K sh @ $20.23 | $253K |
More: insider activity · executive branch · trending